Many clearly dubious claims are being made regarding the issues of trans-resveratrol blood plasma half life and total bioavailability, as well as the capacity of various products to activate sirtuins. The situation has become a bit absurd in our opinion. In an attempt to search out the truth underlying such claims Biotivia invites all competing resveratrol suppliers to an independent evaluation of their product against our resveratrol supplements. Each firm will place substantial funds, in an amount to be mutually agreed, in escrow. Upon independent evaluation of all of the products' bioavailability and SirT1 activation properties in a human cell line, the company whose product is shown to be superior shall receive the total amount pledged by all entries and the results shall be published on all of the company's web sites. Please contact Biotivia to register your product.